Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.5 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |